Switch of immunosuppression from calcineurin inhibitors (CNI) to sirolimus (SRL) in pediatric renal transplantrecipients with CNI toxicity.

被引：0
|
作者：
Hoecker, B
Pieper, A
Feneberg, R
Koepf, S
Weber, LT
Melk, A
Querfeld, U
Toenshoff, B
机构：
[1] Univ Childrens Hosp, Heidelberg, Germany
[2] Univ Childrens Hosp, Berlin, Germany
来源：
PEDIATRIC TRANSPLANTATION | 2005年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
21
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [1] Switch of immunosuppression from calcineurin ihnhibitors (CNI) to sirolimus (SRL) in pediatric renal transplant recipients with CNI toxicity.
    Hoecker, B
    Feneberg, R
    Koepf, S
    Weber, L
    Melk, A
    Toenshoff, B
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 497 - 497
  • [2] Conversion from calcineurin-inhibitor (CNI) based immunosuppression to Sirolimus in chronic CNI toxicity after renal transplantation
    Diekmann, F
    Waiser, J
    Einecke, G
    Dragun, D
    Fritsche, L
    Neumayer, HH
    Budde, K
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 364A - 364A
  • [3] Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: A multicenter study
    Ruiz, JC
    Diekmann, F
    Campistol, JM
    Sanchez-Fructuoso, A
    Rivera, C
    Oliver, J
    Fernandez-Fresnedo, G
    Arias, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3833 - 3835
  • [4] PEDIATRIC EXPERIENCE FOR THE USE OF SIROLIMUS IN RENAL TRANSPLANTATION PATIENT WITH CALCINEURIN INHIBITOR (CNI) TOXICITY
    Tong, Pak Chiu
    Lai, Wai Ming
    Ma, Lap Tak
    Tse, Kei Chiu
    Chiu, Man Chun
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 349 - 349
  • [5] Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients. A multicenter study
    Ruiz, JC
    Diekmann, F
    Campistol, JM
    Sanchez-Fructuoso, A
    Rivera, C
    Oliver, J
    Fernandez-Fresnedo, G
    Arias, M
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 519 - 519
  • [6] Intermediate Results of Sirolimus (SRL) with Reduced Calcineurin Inhibitors (CNI) in Pediatric Heart Transplant (Htx) Recipients - A Controlled Study
    Mathews, K. L.
    Gossett, J.
    Kappelle, P. Vande
    Jellen, G.
    Pahl, E.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S298 - S298
  • [7] SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity
    Hoecker, Britta
    Feneberg, Reinhard
    Koepf, Sabine
    Weber, Lutz T.
    Waldherr, Ruediger
    Wuehl, Elke
    Toenshoff, Burkhard
    [J]. PEDIATRIC TRANSPLANTATION, 2006, 10 (05) : 593 - 601
  • [8] REDUCED INCIDENCE OF MALIGNANCY IN RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN INHIBITORS (CNIS) TO SIROLIMUS (SRL) COMPARED WITH THOSE WHO CONTINUED CNI THERAPY
    Pussell, B.
    Russ, G.
    Walker, R.
    Campbell, S.
    O'Connell, P.
    Kanellis, J.
    Eris, J.
    [J]. NEPHROLOGY, 2006, 11 : A24 - A24
  • [9] EVEROLIMUS (EVE) IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN INHIBITORS (CNI) IMMUNOSUPPRESSION TREATMENT
    Rengel, Manuel
    Abad, Soraya
    Vega, Almudena
    Verdalles, Ursula
    Verde, Eduardo
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 39 - 40
  • [10] Calcineurin inhibitor (CNI) avoidance in pediatric renal transplantation (RTx).
    Harmon, W
    Meyers, K
    McDonald, R
    Ingelfinger, J
    McIntosh, M
    Tinckam, K
    Najafian, N
    Sayegh, M
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 : 57 - 57
12345